In vitro demonstration of the heavy-atom effect for photodynamic therapy

Journal of the American Chemical Society

Volumn 126, Issue 34, 2004, Pages 10619-10631

  Gorman, Aoife ^a   Killoran, John ^a   O'Shea, Caroline ^a   Kenna, Tony ^a   Gallagher, William M ^a   O'Shea, Donal F ^a  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ARRAYS; DISEASE CONTROL; LASERS; MICROSCOPIC EXAMINATION; OXYGEN; PHOTOSENSITIZERS; SCANNING; TOXICITY; TUMORS; X RAY ANALYSIS;

CELLULAR CYTOPLASM; HEAVY-ATOM EFFECT; LASER SCANNING MICROSCOPY IMAGING; PHOTOPHYSICAL CHARACTERISTICS; THERAPEUTIC PARAMETERS;

PHOTODYNAMIC THERAPY;

(3,5 DIPHENYL 1H PYRROL 2 YL)(3,5 DIPHENYLPYRROL 2 YLIDENE)AMINE; [4 BROMO 5 (4 METHOXYPHENYL) 3 PHENYL 1H PYRROL 2 YL][4 BROMO 5 (4 METHOXYPHENYL) 3 PHENYLPYRROL 2 YLIDENE]AMINE; [5 (4 METHOXYPHENYL) 3 PHENYL 1H PYRROL 2 YL][5 (4 METHOXYPHENYL) 3 PHENYLPYRROL 2 YLIDENE]AMINE; AMINE; BORON DERIVATIVE; BORON DIFLUORIDE; BROMINE; CHELATE; PHOTOSENSITIZING AGENT; PYRROLE DERIVATIVE; SINGLET OXYGEN; UNCLASSIFIED DRUG;

ABSORPTION SPECTROSCOPY; ARTICLE; ATOM; CANCER CELL CULTURE; CELL ASSAY; CELLULAR DISTRIBUTION; CONFOCAL LASER MICROSCOPY; CONFORMATIONAL TRANSITION; CONTROL STRATEGY; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; DRUG CYTOTOXICITY; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG STRUCTURE; DRUG SYNTHESIS; FIBROBLAST; HELA CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; PARAMETER; PHOTODYNAMIC THERAPY; REGULATORY MECHANISM; SUBSTITUTION REACTION; SYNTHESIS; TECHNIQUE; UTERINE CERVIX CARCINOMA; X RAY CRYSTALLOGRAPHY;

AZA COMPOUNDS; BORON COMPOUNDS; CRYSTALLOGRAPHY, X-RAY; HELA CELLS; HUMANS; MOLECULAR STRUCTURE; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PYRROLES; SINGLET OXYGEN; SPECTROMETRY, FLUORESCENCE; SPECTROPHOTOMETRY, ULTRAVIOLET;

EID: 4344713237     PISSN: 00027863     EISSN: None     Source Type: Journal    
DOI: 10.1021/ja047649e     Document Type: Article

References (74)

1. For recent reviews, see: (a) Dolmans, D. E. J. G. J.; Fukumura, D.; Jain, R. K. Nature Reviews Cancer 2003, 3, 380.
2. (b) MacDonald, I. J.; Dougherty, T. J. J. Porphyrins Phthalocyanines 2001, 5, 105.
3. (c) Sharman, W. M.; Allen, C. M.; van Lier, J. E. Drug Discovery Today 1999, 4, 507.
4. (d) Dougherty, T. J.; Gomer, C. J.; Henderson, B. W.; Jori, G.; Kessel, D.; Korbelik, M.; Moan, J.; Peng, Q. J. Natl. Cancer Inst. 1998, 90, 889.
5. (e) Bonnett, R. Chem. Soc. Rev. 1995, 24, 19.
6. Oleinick, N. L.; Morris, R. L.; Belichenko, I. Photochem. Photobiol. Sci. 2002, 1, 1.
7. Henderson, B. W.; Dougherty, T. J. Photochem. Photobiol. 1992, 55, 145.
8. Hooper, C. Y.; Guymer, R. H. Clin. Exp. Ophthalmol. 2003, 31, 376 (review).
9. (a) Kereiakes, D. J.; Szyniszewski, A. M.; Wahr, D.; Herrmann, H. C.; Simon, D. I., Rogers, C.; Kramer, P.; Shear, W.; Yeung, A. C.; Shunk, K. A.; Chou, T. M.; Popma, J.; Fitzgerald, P.; Carroll, T. E.; Forer, D.; Adelman, D. C. Circulation 2003, 108, 1310.
10. (b) Hayase, M.; Woodbum, K. W.; Perlroth, J.; Miller, R. A.; Baumgardner, W.; Yock, P. G.; Yeung, A. Cardiovascular Res. 2001, 49, 449.
11. (c) Mansfield, R.; Bown, S.; McEwan, J. Heart 2001, 86, 612 (review).
12. (a) Kömerik, N.; Nakanishi, H.; MacRobert, A. J.; Henderson, B.; Speight, P.; Wilson, M. Antimicrob. Agents Chemother. 2003, 47, 932.
13. (b) Kömerik, N.; Wilson, M. J. Appl. Microbiol. 2002, 92, 618.
14. (c) Wilson, M. J. Appl. Bacteriol. 1993, 75, 299.
15. (a) Hamblin, M. R.; Zahra, T.; Contag, C. H.; McManus, A. T.; Hasan, T. J. Infect. Diseases 2003, 187, 1717.
16. (b) Romanova, N. A.; Brovko, L. Y.; Moore, L.; Pometun, E.; Savitsky, A. P.; Ugarova, N. N.; Griffiths, M. W. Appl. Environ. Microbiol. 2003, 69, 6393.
17. (c) Hamblin, M. R.; O'Donnell, D. A.; Murthy, N.; Contag, C. H.; Hasan, T. Photochem. Photobiol. 2002, 75, 51.
18. Ochsner, M. Drug Res. 1997, 47, 1185.
19. (a) Overholt, B. F.; Panjehpour, M.; Halberg, D. L. Gastrointestinal Endoscopy 2003, 58, 183.
20. (b) Gossner, L.; Stolte, M.; Sroka, R.; Rick, K.; May, A.; Hahn, E. G.; Ell, C. Gastroenterology 1998, 114, 448.
21. (c) Barr, H.; Shepherd, N. A.; Dix, A.; Roberts D. J. H.; Tan, W. C.; Krasner, N. Lancet 1996, 348, 584.
22. (a) Copper, M. P.; Bing Tan, I.; Oppelaar, H.; Ruevekamp, M. C.; Stewart, F. A. Arch. Otolaryngol. 2003, 129, 709.
23. (b) Fan, K. F. M.; Hopper, C.; Speight, P. M.; Buonaccorsi, G. A.; Bown, S. G. Int. J. Cancer 1997, 73, 25.
24. Mang, T. S.; Allison, R.; Hewson, G.; Snider, W.; Moskowitz, R. Cancer J. Sci. Am. 1998, 4, 378.
25. (a) Koudinova, N. V.; Pinthus, J. H.; Brandis, A.; Brenner, O.; Bendel, P.; Ramon, J.; Eshhar, Z.; Scherz, A.; Salomon, Y. Int. J. Cancer 2003, 104, 782.
26. (b) Chen, Q.; Huang, Z.; Luck, D.; Beckers, J.; Brun, P. H.; Wilson, B. C.; Scherz, A.; Salomon, Y.; Hetzel, F. W. Photochem. Photobiol. 2002, 76, 438.
27. Sessler, J. L.; Miller, R. A. Biochem. Pharmacol. 2000, 59, 733 (review).
28. (a) Bench, B. A.; Beveridge, A.; Sharman, W. M.; Diebold, G. J.; van Lier J. E.; Gorun, S. M. Angew. Chem., Int. Ed. 2002, 41, 748.
29. (b) Ball, D. J.; Mayhew, S.; Wood, S. R.; Griffiths, J.; Vernon, D. I.; Brown, S. B. Photochem. Photobiol. 1999, 69, 390.
30. (c) Hu, M.; Brasseur, N.; Yildiz, S. Z.; van Lier, J. E.; Leznoff, C. C. J. Med. Chem. 1998, 41, 1789.
31. (d) Allemann, E.; Brasseur, N.; Kudrevich, S. V.; La Madeleine, C.; van Lier, J. E. Int. J. Cancer 1997, 72, 289.
32. Wainwright, M. Chem. Soc. Rev. 1996, 351 (review).
33. (a) Wainwright, M.; Crossley, K. B. J. Chemother. 2002, 14, 431 (review).
34. (b) Mellish, K. J.; Cox, R. D.; Vernon, D. I.; Griffiths, J.; Brown, S. B. Photochem. Photobiol. 2002, 75, 392.
35. (c) Wainwright, M.; Phoenix, D. A.; Rice, L.; Burrow, S. M.; Waring, J. J. Photochem. Photobiol. B 1997, 40, 233.
36. (d) Orth, K.; Ruck, A.; Stanescu, A.; Berger, H. G. Lancet 1995, 345, 519.
37. (a) Tong, Z.; Singh, G.; Rainbow, A. J. Photochem. Photobiol. 2001, 74, 707.
38. (b) Frimberger, A. E.; Moore, A. S.; Cincotta, L.; Cotter, S. M.; Foley, J. R. Clinical Cancer Res. 1944, 4, 2207.
39. (c) Cincotta, L.; Foley, J. W.; Maceachern, T.; Lampros, E.; Cincotta, A. H. Cancer Res. 1994, 54, 1249.
40. (a) Detty, M. R.; Merkel, P. B. J Am. Chem. Soc. 1990, 112, 3845.
41. (b) Leonard, K. A.; Nelen, M. I.; Anderson, L. T.; Gibson, S. L.; Hilf, R.; Detty, M. R. J. Med. Chem. 1999, 42, 3942.
42. (c) Leonard, K. A.; Hall, J. P.; Nelen, M. I.; Davies, S. R.; Gollnick, S. O.; Camacho, S.; Oseroff, A. R.; Gibson, S. L.; Hilf, R.; Detty, M. R. J. Med. Chem. 2000, 43, 4488.
43. (d) Brennan N. K.; Hall, J. P.; Davies, S. R.; Gollnick, S. O.; Oseroff, A. R.; Gibson, S. L.; Hilf, R.; Detty, M. R. J. Med. Chem. 2002, 45, 5123.
44. (a) Williamson, L. M.; Cardigan, R.; Prowse, C. V. Transfusion 2003, 43, 1322 (review).
45. (b) Jockusch, S.; Lee, D.; Turro, N. J.; Leonard, E. F. Proc. Natl. Acad. Sci. U.S.A. 1996, 93, 7446.
46. Wilson, B. C.; Patterson, M. S.; Lilge, L. Lasers Med. Sci. 1997, 12, 182 (review).
47. Turro, N. J. In Modern Molecular Photochemistry; University Science Books: Sausalito, CA, 1991; pp 191-195.
48. Rogers, M. A. T. J. Chem. Soc. 1943, 596.
49. (a) Killoran, J.; Allen, L.; Gallagher, J. F.; Gallagher, W. M.; O'Shea, D. F. Chem. Commun. 2002, 1862.
50. (b) O'Shea D.; Killoran J.; Gallagher, W. PCT, WO 03/080627 Al.
51. Wattanasin, S.; Murphy, W. S. Synthesis 1980, 647.
52. Gelderblom, H.; Verweij, J.; Nooter, K.; Sparreboom, A. Eur. J. Cancer 2001, 37, 1590.
53. Dougherty, T. J.; Potter, W. R. J. Photochem. Photobiol. B 1991, 8, 233.
54. Lower, S. K.; El-Sayed, M. A. Chem. Rev. 1966, 66, 199.
55. (a) Yuster, P.; Weissman, S. I. J. Chem. Phys. 1949, 17, 1182.
56. (b) McClure, D. S. J. Chem. Phys. 1949, 17, 905.
57. (a) Koziar, J. C.; Cowan, D. O. Acc. Chem. Res. 1978, 334 (review).
58. (b) McGlynn, S. P.; Reynolds, M. J.; Daigre, G. W.; Christodoyleas, N. D. J. Phys. Chem. 1962, 66, 2499.
59. (c) Kasha, M. J. Chem. Phys. 1952, 20, 71.
60. Chandra, A. K.; Turro, N. J.; Lyons, A. L., Jr.; Stone, P. J. Am. Chem. Soc. 1978, 100, 4964.
61. For this description, we regard the fused five-six-five-membered rings as the central sensitizer and the aryl rings as peripheral substituents.
62. (a) You, Y.; Gibson, S. L.; Hilf, R.; Davies, S. R.; Oseroff, A. R.; Roy, I.; Ohulchanskyy, T. Y.; Bergey, E. J.; Detty, M. R. J. Med. Chem. 2003, 46, 3743.
63. (b) Hilmey, D. G.; Abe, M.; Nelen, M. I.; Stilts, C. E.; Baker, G. A.; Baker, S. N.; Bright, F. V.; Davies, S. R.; Gollnick, S. O.; Oseroff, A. R.; Gibson, S. L.; Hilf, R.; Detty, M. R. J. Med. Chem. 2002, 45, 449.
64. (a) Pineiro, M.; Rocha Gonsalves, A. M. d'A.; Pereira, M. M.; Formosinho, S. J.; Arnaut, L. G. J Phy. Chem. A 2002, 106, 3787.
65. (b) Azenha, E. G.; Serra, A. C.; Pineiro, M.; Pereira, M. M.; de Melo, J. S.; Arnaut, L. G.; Formosinho, S. J.; Rocha Gonsalves, A. M. d'A. Chem. Phy. 2002, 280, 177.
66. Gollnick, K.; Griesbeck, A. Tetrahedron 1985, 41, 2057.
67. Kochevar, I. E.; Redmond, R. W. Methods Enzymol. 2000, 319, 20.
68. Reddi, E.; Rodgers, M. A. J.; Spikes, J. D.; Jori, G. Photochem. Photobiol. 1984, 40, 415.
69. Shotton, D. M. J. Cell Sci. 1989, 94, 175.
70. Suzuki, T.; Matsuzaki, T.; Takata, K. Acta Histochem. Cytochem. 1998, 31, 297.
71. No light or dark toxicity was observed for CrEL alone when tested in our assay system.
72. The light source was either a Waldmann PDT 1200 L instrument with an emission spectrum of 600-750 nm or a 500 W halogen lamp combined with red and water filters with an emission spectrum of 600-750 nm. Both systems gave comparable assay data.
73. Sol, V.; Blais, J. C.; Carré, V.; Granet, R.; Guilloton, M.; Spiro, M.; Krausz, P. J. Org. Chem. 1999, 64, 4431.
74. Stiel, H.; Teuchner, K.; Paul, A.; Freyer, W.; Leupold, D. J. Photochem. Photobiol. A 1994, 80, 289.